Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
Add more filters










Publication year range
1.
Colloids Surf B Biointerfaces ; 181: 48-57, 2019 Sep 01.
Article in English | MEDLINE | ID: mdl-31121381

ABSTRACT

Carbon dots (CDots) for their excellent optical and other properties have been widely pursued for potential biomedical applications, in which a more comprehensive understanding on the cellular behaviors and mechanisms of CDots is required. For such a purpose, two kinds of CDots with surface passivation by 3-ethoxypropylamine (EPA-CDots) and oligomeric polyethylenimine (PEI-CDots) were selected for evaluations on their uptakes by human cervical carcinoma HeLa cells at three cell cycle phases (G0/G1, S and G2/M), and on their different internalization pathways and translocations in cells. The results show that HeLa cells could internalize both CDots by different pathways, with an overall slightly higher internalization efficiency for PEI-CDots. The presence of serum in culture media could have major effects, significantly enhancing the cellular uptake of EPA-CDots, yet markedly inhibiting that of PEI-CDots. The HeLa cells at different cell cycle phases have different behaviors in taking up the CDots, which are also affected by the different dot surface moieties and serum in culture media. Mechanistic implications of the results and the opportunities associated with an improved understanding on the cellular behaviors of CDots for potentially the manipulation and control of their cellular uptakes and translocations are discussed.


Subject(s)
Carbon/pharmacokinetics , Quantum Dots/chemistry , Carbon/chemistry , Cell Survival/drug effects , HeLa Cells , Humans , Particle Size , Polyethyleneimine/chemistry , Polyethyleneimine/pharmacokinetics , Propylamines/chemistry , Propylamines/pharmacokinetics , Surface Properties , Tumor Cells, Cultured
2.
Toxicol Lett ; 295: 74-85, 2018 Oct 01.
Article in English | MEDLINE | ID: mdl-29859860

ABSTRACT

The fast growing applications of ZnO nanoparticles (NPs) in food sector and other fields enhance the exposure possibility of human beings to ZnO NPs including via oral administration route. Although the oral toxicity of ZnO NPs has been studied, most of the research was performed on the normal animal models. Therefore, the understanding of the biological consequence of ZnO NPs on the population with diseases, especially gastrointestinal disease, is extremely limited. In this study, a mice model of inflammatory bowel disease (IBD) induced by indomethacin has been developed to comprehensively investigated the bioeffects of ZnO NPs on the specific population. The effect of the intestinal inflammation/injury on the distribution and toxicity of orally administrated ZnO NPs (nZnO, 20 nm × 100 nm and mZnO, ∼200 nm) in mice were analyzed. The results showed that there was a difference in the distribution of Zn and the essential trace elements (Fe and Cu) between the IBD mice and the normal mice. We also observed an obvious size effect. Higher hepatic Zn was detected in the IBD mice post-exposure to ZnO NPs, especially bigger ZnO NPs. In addition, the histopathological examination of main organs and biological parameters analysis showed that ZnO NPs caused slight toxicity to the liver and kidneys in the IBD mice. Our findings highlight the importance of the health status of animals on the bioeffects of nanomaterials.


Subject(s)
Inflammatory Bowel Diseases/metabolism , Intestines/drug effects , Metal Nanoparticles/toxicity , Zinc Oxide/toxicity , Administration, Oral , Animals , Copper/metabolism , Disease Models, Animal , Indomethacin , Inflammatory Bowel Diseases/chemically induced , Inflammatory Bowel Diseases/pathology , Intestinal Mucosa/metabolism , Intestines/pathology , Iron/metabolism , Kidney/drug effects , Kidney/metabolism , Kidney/pathology , Liver/drug effects , Liver/metabolism , Liver/pathology , Male , Mice, Inbred ICR , Tissue Distribution , Zinc Oxide/administration & dosage , Zinc Oxide/metabolism
3.
Proc Natl Acad Sci U S A ; 115(1): E34-E43, 2018 01 02.
Article in English | MEDLINE | ID: mdl-29255034

ABSTRACT

To impart biomedical functions to nanoparticles (NPs), the common approach is to conjugate functional groups onto NPs by dint of the functions of those groups per se. It is still beyond current reach to create protein-like specific interactions and functions on NPs by conformational engineering of nonfunctional groups on NPs. Here, we develop a conformational engineering method to create an NP-based artificial antibody, denoted "Goldbody," through conformational reconstruction of the complementary-determining regions (CDRs) of natural antibodies on gold NPs (AuNPs). The seemingly insurmountable task of controlling the conformation of the CDR loops, which are flexible and nonfunctional in the free form, was accomplished unexpectedly in a simple way. Upon anchoring both terminals of the free CDR loops on AuNPs, we managed to reconstruct the "active" conformation of the CDR loops by tuning the span between the two terminals and, as a result, the original specificity was successfully reconstructed on the AuNPs. Two Goldbodies have been created by this strategy to specifically bind with hen egg white lysozyme and epidermal growth factor receptor, with apparent affinities several orders of magnitude stronger than that of the original natural antibodies. Our work demonstrates that it is possible to create protein-like functions on NPs in a protein-like way, namely by tuning flexible surface groups to the correct conformation. Given the apparent merits, including good stability, of Goldbodies, we anticipate that a category of Goldbodies could be created to target different antigens and thus used as substitutes for natural antibodies in various applications.


Subject(s)
Antibodies, Monoclonal/chemistry , Complementarity Determining Regions/chemistry , Gold/chemistry , Metal Nanoparticles/chemistry , Protein Conformation
4.
Biomaterials ; 108: 35-43, 2016 11.
Article in English | MEDLINE | ID: mdl-27619238

ABSTRACT

Nanoparticles are regularly used as contrast agents in bioimaging. Unlike other agents such as composite materials, nanoparticles can also be used for treating as well as imaging disease. Here we synthesized lanthanide functionalized gold nanoparticles that can be used for both imaging and therapy in vivo. That is a multifunctional nanoplatform was developed based on a simple and versatile method, by incorporating 10-nm gold nanoparticles and lanthanide ions (Gd(3+) and Yb(3+)), denoted as LnAu nanoparticles hereby. The LnAu nanoparticles were then surface-modified using a PEGylated amphiphilic polymer (C18MH-mPEG), and the resulting PEG modified LnAu nanoparticles (PEG-LnAu) display good monodispersion in water and good solubility in biological media. Due to the low toxicity in vitro and in vivo (as determined by a cell viability assay and histological and serum biochemistry analysis), the PEG-LnAu nanoparticles can be successfully applied to in vivo magnetic resonance imaging (MRI), in vivo computed tomography (CT) imaging and photothermal therapy (PTT) for tumor-bearing mice. Therefore, the present work developed an easy yet powerful strategy to combine lanthanide ions and gold nanoparticles to a unified nanoplatform for integrating bioimaging and therapy.


Subject(s)
Magnetic Resonance Imaging/methods , Metal Nanoparticles/therapeutic use , Neoplasms, Experimental/diagnostic imaging , Neoplasms, Experimental/therapy , Phototherapy/methods , Theranostic Nanomedicine/methods , Tomography, X-Ray Computed/methods , Animals , Cell Line, Tumor , Coated Materials, Biocompatible/chemistry , Contrast Media/chemical synthesis , Gold/chemistry , Gold/therapeutic use , HeLa Cells , Humans , Lanthanoid Series Elements/chemistry , Lanthanoid Series Elements/therapeutic use , Metal Nanoparticles/chemistry , Metal Nanoparticles/ultrastructure , Mice , Polyethylene Glycols/chemistry , Treatment Outcome
5.
Int J Mol Sci ; 17(6)2016 Jun 21.
Article in English | MEDLINE | ID: mdl-27338357

ABSTRACT

Extensive utilization increases the exposure of humans to Ag nanoparticles (NPs) via the oral pathway. To comprehensively address the action of Ag NPs to the gastrointestinal systems in real situations, i.e., the long-term low-dose exposure, we evaluated and compared the toxicity of three Ag NPs (20-30 nm with different surface coatings) to the human intestine cell Caco-2 after 1-day and 21-day exposures, using various biological assays. In both the short- and long-term exposures, the variety of surface coating predominated the toxicity of Ag NPs in a descending order of citrate-coated Ag NP (Ag-CIT), bare Ag NP (Ag-B), and poly (N-vinyl-2-pyrrolidone)-coated Ag NP (Ag-PVP). The short-term exposure induced cell growth inhibition and death. The cell viability loss appeared after cells were exposed to 0.7 µg/mL Ag-CIT, 0.9 µg/mL Ag-B or >1.0 µg/mL Ag-PVP for 24 h. The short-term and higher-dose exposure also induced reactive oxygen species (ROS) generation, mitochondrial damage, cell membrane leakage, apoptosis, and inflammation (IL-8 level). The long-term exposure only inhibited the cell proliferation. After 21-day exposure to 0.4 µg/mL Ag-CIT, the cell viability dropped to less than 50%, while cells exposed to 0.5 µg/mL Ag-PVP remained normal as the control. Generally, 0.3 µg/mL is the non-toxic dose for the long-term exposure of Caco-2 cells to Ag NPs in this study. However, cells presented inflammation after exposure to Ag NPs with the non-toxic dose in the long-term exposure.


Subject(s)
Metal Nanoparticles/adverse effects , Mitochondria/drug effects , Apoptosis , Caco-2 Cells , Citrates/chemistry , Humans , Metal Nanoparticles/chemistry , Metal Nanoparticles/toxicity , Mitochondria/metabolism , Polyvinyls/chemistry , Pyrrolidinones/chemistry , Reactive Oxygen Species/metabolism , Silver/chemistry
6.
Colloids Surf B Biointerfaces ; 142: 65-73, 2016 Jun 01.
Article in English | MEDLINE | ID: mdl-26930035

ABSTRACT

The physicochemical properties of nanomaterials play crucial roles in determining their biological effects. Agglomeration of nanomaterials in various systems is a common phenomenon, however, how agglomeration affects the biological consequence of nanomaterials has not been well investigated because of its complexity. Herein, we prepared variable sized agglomerates of oxidized multi-walled carbon nanotubes (O-MWCNTs) by using Ca(2+) and studied their cellular uptake and cytotoxicity in HeLa cells. We found the altered property of O-MWCNTs agglomerates could be controlled and adjusted by the amount of Ca(2+). Agglomeration remarkably facilitated the cellular uptake of O-MWCNTs at the initial contact stage, due to the easy contact of agglomerates with cells. But agglomeration did not induce evident cytotoxicity when the concentration of O-MWCNTs was less than 150µg/mL. That was assayed by cell proliferation, membrane integrity, apoptosis and ROS generation. This study suggests us that the biological behaviors of nanomaterials could be altered by their states of agglomeration.


Subject(s)
Calcium/chemistry , Cell Proliferation/drug effects , Nanotubes, Carbon/chemistry , Apoptosis/drug effects , Biological Transport , Cell Membrane/chemistry , Cell Membrane/drug effects , Cell Survival/drug effects , Flocculation , HeLa Cells , Humans , Nanotubes, Carbon/ultrastructure , Particle Size , Reactive Oxygen Species/agonists , Reactive Oxygen Species/metabolism
7.
Nanomedicine (Lond) ; 10(13): 2005-16, 2015.
Article in English | MEDLINE | ID: mdl-26135851

ABSTRACT

AIMS: Developing safe and efficient nano vectors is critical for the success of siRNA therapy. MATERIALS & METHODS: By encapsulating red fluorescent protein (RFP) with chitosan (CS), a dual-functional siRNA delivery nano vector, RFP@CS, has been synthesized. RESULTS: RFP@CS has an optimum size of 7-23 nm for siRNA delivery; and the fluorescence of RFP, protected by CS coating, provides an excellent probe to track the delivery of siRNA. RFP@CS delivers siRNA efficiently into cells and the targeted gene could be completely silenced even after 48 h. No cytotoxicity or acute toxicity in mice was observed. CONCLUSION: The high transfection efficacy and safety demonstrate RFP@CS is a promising nano vector for the gene therapy.


Subject(s)
Chitosan/chemistry , Luminescent Proteins/chemistry , Nanoparticles/chemistry , RNA Interference , RNA, Small Interfering/administration & dosage , Transfection , Animals , Cell Line , Chitosan/analysis , Fluorescence , HeLa Cells , Humans , Luminescent Proteins/analysis , Male , Mice, Inbred BALB C , Nanoparticles/analysis , Nanoparticles/ultrastructure , RNA, Small Interfering/genetics , Transfection/methods , Red Fluorescent Protein
8.
J Appl Toxicol ; 35(10): 1169-78, 2015 Oct.
Article in English | MEDLINE | ID: mdl-26106068

ABSTRACT

Titanium dioxide nanoparticles (TiO2 NPs) are widely found in food-related consumer products. Understanding the effect of TiO2 NPs on the intestinal barrier and absorption is essential and vital for the safety assessment of orally administrated TiO2 NPs. In this study, the cytotoxicity and translocation of two native TiO2 NPs, and these two TiO2 NPs pretreated with the digestion simulation fluid or bovine serum albumin were investigated in undifferentiated Caco-2 cells, differentiated Caco-2 cells and Caco-2 monolayer. TiO2 NPs with a concentration less than 200 µg ml(-1) did not induce any toxicity in differentiated cells and Caco-2 monolayer after 24 h exposure. However, TiO2 NPs pretreated with digestion simulation fluids at 200 µg ml(-1) inhibited the growth of undifferentiated Caco-2 cells. Undifferentiated Caco-2 cells swallowed native TiO2 NPs easily, but not pretreated NPs, implying the protein coating on NPs impeded the cellular uptake. Compared with undifferentiated cells, differentiated ones possessed much lower uptake ability of these TiO2 NPs. Similarly, the traverse of TiO2 NPs through the Caco-2 monolayer was also negligible. Therefore, we infer the possibility of TiO2 NPs traversing through the intestine of animal or human after oral intake is quite low. This study provides valuable information for the risk assessment of TiO2 NPs in food.


Subject(s)
Food Additives/toxicity , Intestines/drug effects , Metal Nanoparticles/toxicity , Titanium/toxicity , Caco-2 Cells , Cell Differentiation/drug effects , Cell Membrane/drug effects , Cell Proliferation/drug effects , Cell Survival/drug effects , Humans , Intestinal Mucosa/metabolism , Reactive Oxygen Species/metabolism
9.
J Appl Toxicol ; 34(4): 424-35, 2014 Apr.
Article in English | MEDLINE | ID: mdl-24302550

ABSTRACT

Silica nanoparticles (NPs) have been widely used in food products as an additive; however, their toxicity and safety to the human body and the environment still remain unclear. As a food additive, silica NPs firstly enter the human gastrointestinal tract along with food, thus their gastrointestinal toxicity deserves thorough study. Herein, we evaluated the toxicity of food additive silica NPs to cells originating from the gastrointestinal tract. Four silica NP samples were introduced to human gastric epithelial cell GES-1 and colorectal adenocarcinoma cell Caco-2 to investigate the effect of silica sample, exposure dose and exposure period on the morphology, viability and membrane integrity of cells. The cell uptake, cellular reactive oxygen species (ROS) level, cell cycle and apoptosis were determined to reveal the toxicity mechanism. The results indicate that all four silica NPs are safe for both GES-1 and Caco-2 cells after 24-h exposure at a concentration lower than 100 µg ml(-1) . At a higher concentration and longer exposure period, silica NPs do not induce the apoptosis/necrosis of cells, but arrest cell cycle and inhibit the cell growth. Notably, silica NPs do not pass through the Caco-2 cell monolayer after 4-h contact, indicating the low potential of silica NPs to cross the gastrointestinal tract in vivo. Our findings indicate that silica NPs could be used as a safe food additive, but more investigations, such as long-term in vivo exposure, are necessary in future studies.


Subject(s)
Epithelial Cells/drug effects , Food Additives/toxicity , Nanoparticles/toxicity , Silicon Dioxide/toxicity , Apoptosis/drug effects , Caco-2 Cells , Cell Cycle/drug effects , Cell Proliferation/drug effects , Cell Survival/drug effects , Epithelial Cells/metabolism , Epithelial Cells/pathology , Food Additives/chemistry , Humans , Microscopy, Electron, Transmission , Microscopy, Fluorescence , Nanoparticles/chemistry , Particle Size , Reactive Oxygen Species/metabolism , Silicon Dioxide/chemistry , Surface Properties
10.
Nanomedicine (Lond) ; 8(12): 2007-25, 2013 Dec.
Article in English | MEDLINE | ID: mdl-24279490

ABSTRACT

Nanotechnology has stepped into the food industry, from the farm to the table at home, in order to improve the taste and nutritional value, extend the shelf-life and monitor the food quality. In fact, as consumers we have already been in contact, via oral exposure, with a number of food products containing engineered nanomaterials (ENMs) more often than most people think. However, the fate of ENMs after entering the GI tract of the human body is not yet clearly understood. Hence, the related safety issue is raised, and attracts much attention and wide debate from the public, even including protest demonstrations against nanotechnology in food. In this review, we summarize the up-to-date information about the characterization and safety evaluation of common inorganic ENMs (with a focus on silver, titanium dioxide, silica and zinc oxide nanoparticles) in food. Based on the literature, a whole scenario of the safety issue of these ENMs in food and an outlook on the future studies are given.


Subject(s)
Food Safety/methods , Nanostructures/adverse effects , Nanostructures/analysis , Animals , Humans , Nanostructures/toxicity , Silicon Dioxide/adverse effects , Silicon Dioxide/analysis , Silicon Dioxide/toxicity , Silver/adverse effects , Silver/analysis , Silver/toxicity , Titanium/adverse effects , Titanium/analysis , Titanium/toxicity , Zinc Oxide/adverse effects , Zinc Oxide/analysis , Zinc Oxide/toxicity
SELECTION OF CITATIONS
SEARCH DETAIL
...